Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11868272 | 0.83 | CYP3A4 (0.39) | TTRSLC6A4TSHRKDM4EALDH1A1 | |
| SCHEMBL4135418 | 0.83 | TTR (0.37) | TTRSLC6A4TSHRALDH1A1 | |
| SCHEMBL28803630 | 0.83 | TTR (0.32) | TTR | |
| SCHEMBL24038795 | 0.81 | ALOX15 (0.41) | TTRTSHRCA1CA2KDM4E | |
| SCHEMBL5181545 | 0.77 | SLC6A4 (0.31) | SLC6A4TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL2090992 | 0.77 | ALDH1A1 (0.38) | TTRSLC6A4TSHRCA2ALDH1A1 | |
| SCHEMBL2090990 | 0.77 | HPGD (0.31) | SLC6A4KDM4EALDH1A1LMNAMAPT | |
| SCHEMBL11193422 | 0.77 | SLC6A4 (0.31) | SLC6A4KDM4EALDH1A1LMNAMAPT | |
| SCHEMBL5181553 | 0.77 | IDO1 (0.41) | SLC6A4KDM4EALDH1A1LMNAMAPT | |
| SCHEMBL3490684 | 0.77 | IDO1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010037037-A1 | Oximesulfonic acid esters and the use thereof as latent sulfonic acids | CIBA SPEICIALTY CHEMICALS CORP. | 2001-11-01 | — | — | US | disclosed |
| US-6017675-A | POLYMERIZATION CATALYST | CIBA SPECIALTY CHEMIALS CORPORATION (US) | 2000-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010037037-A1 | Oximesulfonic acid esters and the use thereof as latent sulfonic acids | QSOX1, HAO2, PAH | TTR 3911/4885SLC6A4 3733/4885TSHR 2828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.